Supratotal resection in glioma: a systematic review

Ricard, 2012, Primary brain tumours in adults, Lancet, 379, 1984, 10.1016/S0140-6736(11)61346-9

Mandonnet, 2003, Continuous growth of mean tumor diameter in a subset of grade II gliomas, Ann Neurol, 53, 524, 10.1002/ana.10528

Brandes, 2008, Glioblastoma in adults, Crit Rev Oncol Hematol, 67, 139, 10.1016/j.critrevonc.2008.02.005

Miranda, 2017, Breaching barriers in glioblastoma. Part I: molecular pathways and novel treatment approaches, Int J Pharm, 531, 372, 10.1016/j.ijpharm.2017.07.056

Bush, 2017, Current and future strategies for treatment of glioma, Neurosurg Rev, 40, 1, 10.1007/s10143-016-0709-8

Berger, 2009, Surgical resection strategies for optimizing glioma removal, Neuro Oncol, 11, 879

Berger, 1994, The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas, Cancer, 74, 1784, 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D

Brown, 2016, Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis, JAMA Oncol, 2, 1460, 10.1001/jamaoncol.2016.1373

D’Amico, 2017, Extent of resection in glioma-a review of the cutting edge, World Neurosurg, 103, 538, 10.1016/j.wneu.2017.04.041

Grabowski, 2014, Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma, J Neurosurg, 121, 1115, 10.3171/2014.7.JNS132449

Hervey-Jumper, 2016, Maximizing safe resection of low- and high-grade glioma, J Neurooncol, 130, 269, 10.1007/s11060-016-2110-4

Sanai, 2008, Glioma extent of resection and its impact on patient outcome, Neurosurgery, 62, 753, 10.1227/01.neu.0000318159.21731.cf

Snyder, 2012, The impact of extent of resection on malignant transformation of pure oligodendrogliomas, J Neurosurg, 117, A429

Yan, 2017, Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients, J Neurosurg, 126, 234, 10.3171/2016.1.JNS152153

Kelly, 1987, Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms, J Neurosurg, 66, 865, 10.3171/jns.1987.66.6.0865

Silbergeld, 1997, Isolation and characterization of human malignant glioma cells from histologically normal brain, J Neurosurg, 86, 525, 10.3171/jns.1997.86.3.0525

Matsukado, 1961, The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice, J Neurosurg, 18, 636, 10.3171/jns.1961.18.5.0636

Pallud, 2010, Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities, Neurology, 74, 1724, 10.1212/WNL.0b013e3181e04264

Kageji, 2004, Histopathological findings in autopsied glioblastoma patients treated by mixed neutron beam BNCT, J Neurooncol, 68, 25, 10.1023/B:NEON.0000024725.31515.22

Lacroix, 2001, A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival, J Neurosurg, 95, 190, 10.3171/jns.2001.95.2.0190

Smith, 2008, Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas, J Clin Oncol, 26, 1338, 10.1200/JCO.2007.13.9337

Cahill, 2012, IDH1 status determines the survival benefit of surgical resection for malignant astrocytomas, J Neurosurg, 117, A388

Bette, 2016, Value of early postoperative FLAIR volume dynamic in glioma with no or minimal enhancement, World Neurosurg, 91, 548, 10.1016/j.wneu.2016.03.034

Quan, 2018, Increasing FLAIR signal intensity in the postoperative cavity predicts progression in gross-total resected high-grade gliomas, J Neurooncol, 137, 631, 10.1007/s11060-018-2758-z

Hervey-Jumper, 2014, Role of surgical resection in low- and high-grade gliomas, Curr Treat Options Neurol, 16, 284, 10.1007/s11940-014-0284-7

Mohammadi, 2014, Use of high-field intraoperative magnetic resonance imaging to enhance the extent of resection of enhancing and nonenhancing gliomas, Neurosurgery, 74, 339, 10.1227/NEU.0000000000000278

Leroy, 2018, High-field intraoperative MRI in glioma surgery: a prospective study with volumetric analysis of extent of resection and functional outcome, Neurochirurgie, 64, 155, 10.1016/j.neuchi.2018.02.003

Mansouri, 2016, The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: a systematic review, Cancer, 122, 2469, 10.1002/cncr.30088

Jenkinson, 2018, Intraoperative imaging technology to maximise extent of resection for glioma, Cochrane Database Syst Rev, 1, CD012788

Duffau, 2016, Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up, Acta Neurochir (Wien), 158, 51, 10.1007/s00701-015-2621-3

Duffau, 2012, Awake surgery for incidental WHO grade II gliomas involving eloquent areas, Acta Neurochir (Wien), 154, 575, 10.1007/s00701-011-1216-x

Duffau, 2013, Surgery for diffuse low-grade gliomas (DLGG) oncological considerations, Diffuse Low-Grade Gliomas in Adults, 359, 10.1007/978-1-4471-2213-5_23

Yordanova, 2017, Supratotal resection of diffuse gliomas—an overview of its multifaceted implications, Neurochirurgie, 63, 243, 10.1016/j.neuchi.2016.09.006

Yordanova, 2011, Awake surgery for WHO grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection. Clinical article, J Neurosurg, 115, 232, 10.3171/2011.3.JNS101333

Li, 2016, The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection, J Neurosurg, 124, 977, 10.3171/2015.5.JNS142087

Eyüpoglu, 2016, Supra-complete surgery via Dual intraoperative Visualization Approach (DiVA) prolongs patient survival in glioblastoma, Oncotarget, 7, 25755, 10.18632/oncotarget.8367

Lima, 2017, Surgical resection of incidental diffuse gliomas involving eloquent brain areas. Rationale, functional, epileptological and oncological outcomes, Neurochirurgie, 63, 250, 10.1016/j.neuchi.2016.08.007

Lima, 2015, Is there a risk of seizures in “preventive” awake surgery for incidental diffuse low-grade gliomas, J Neurosurg, 122, 1397, 10.3171/2014.9.JNS141396

Pessina, 2017, Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience, J Neurooncol, 135, 129, 10.1007/s11060-017-2559-9

Sanai, 2018, Surgical oncology for gliomas: the state of the art, Nat Rev Clin Oncol, 15, 112, 10.1038/nrclinonc.2017.171

Beiko, 2014, IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection, Neuro Oncol, 16, 81, 10.1093/neuonc/not159

Mampre, 2018, Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes, Br J Neurosurg, 1

Motomura K, Chalise L, Ohka F, Aoki K, Tanahashi K, Hirano M, Nishikawa T, Wakabayashi T, Natsume A. World Neurosurg. 2018 Jul 31. pii: S1878-8750(18)31671-1. doi: 10.1016/j.wneu.2018.07.193. [Epub ahead of print]

Rapp, 2017, Recurrence pattern analysis of primary glioblastoma, World Neurosurg, 103, 733, 10.1016/j.wneu.2017.04.053

Duffau, 2014, Is supratotal resection of glioblastoma in noneloquent areas possible, World Neurosurg, 82, e101, 10.1016/j.wneu.2014.02.015

Asher, 2013, The National Neurosurgery Quality and Outcomes Database and NeuroPoint Alliance: rationale, development, and implementation, Neurosurg Focus, 34, E2, 10.3171/2012.10.FOCUS12311

McGirt, 2013, The National Neurosurgery Quality and Outcomes Database (N2QOD): general overview and pilot-year project description, Neurosurg Focus, 34, E6, 10.3171/2012.10.FOCUS12297